Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021. He will be a fellow of Merton College. A donation from the WA Handley Trust endowed the first Chair of Psychiatry in the University of Oxford’s Department of Psychiatry, which was founded in 1969.

John Geddes
It’s a true honour to be appointed to a statutory chair at Oxford University. Even in normal times Oxford is an astonishing place and I am simply awestruck by what this place has done in the battle against the virus. The WA Handley Chair will help me ensure that we learn from this to bring the same urgency, widespread collaboration and intellectual inspiration to bear on mental health. - Professor John Geddes, Head of Department of Psychiatry

The Department of Psychiatry and Merton College, one of the oldest colleges in Oxford with a strong commitment to excellence in research and teaching, held a rigorous search and selection process for this prestigious clinical academic post. The position provides an unparalleled opportunity to develop and sustain a large scale research programme, supported by the world-leading clinical research infrastructure in Oxford.

Mental health research is a priority for the University of Oxford, which is working closely with Oxford Health NHS Foundation Trust through the NIHR Oxford Health Biomedical Research Centre.

Previous post holders include the late Professor Michael Gelder, the founder of the Department of Psychiatry at the University of Oxford, and Professor Guy Goodwin.

Read the full story on the Department of Psychiatry website

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.